Newsbenzinga
Denali Therapeutics Q2 2026 Earnings Call Transcript
· Published
Article summary
On Thursday, Denali Therapeutics (NASDAQ:DNLI) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call
An excerpt from the original article.
Comments —
Loading comments…